cvot tirzepatide SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of What do topline data from

Decreased Appetite: Some individuals may experience a decrease in appetite while taking GLP-1 medications, which can be both a desired effect (supporting weight loss) and a potential side effect (leading to inadequate calorie intake)

If Wednesdays are your highest-stress work days, avoid injections that would put day 2-3 post-injection on Wednesday

Always consult with your healthcare provider before starting, stopping, or modifying any medication regimen

Related Compounds Researchers investigating BPC-157 often also study TB-500, as the two peptides are frequently examined together in tissue-repair research, including combination formulations such as the BPC-157/TB-500 blend, Klow, and Glow available in the catalog